Concepedia

A. Raschig

AR

7

Publications

289

Citations

7

H-Index

1979

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Philipps University of Marburg

Universität Hamburg

University of Zurich

Freie Universität Berlin

A. Raschig is an author at Boehringer Ingelheim (Germany) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1979–2007

7

Publications

7

Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ<sub>42</sub>in patients with Alzheimer's disease

Christoph Höck, Alessia Maddalena, A. Raschig et al. · Amyloid · 2003 · 109 citations

Treatment with the Selective Muscarinic Agonist Talsaclidine Decreases Cerebrospinal Fluid Levels of Total Amyloid β‐Peptide in Patients with Alzheimer's Disease

C. Hock, Alessia Maddalena, Isabella Heuser et al. · Annals of the New York Academy of Sciences · 2000 · 53 citations

Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man

M. Wienrich, D. Meier, Helmut A. Ensinger et al. · Life Sciences · 2001 · 40 citations

, , +6

Differences in psychic performance with guanfacine and clonidine in normotensive subjects.

J Kugler, R Seus, R. Krauskopf et al. · British Journal of Clinical Pharmacology · 1980 · 33 citations · Full text

, , +20

Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease

Thorsten Lehr, Alexander Staab, Christiane Tillmann et al. · British Journal of Clinical Pharmacology · 2007 · 20 citations · Full text

Rows per page

1–5 of 7